Several lines of evidence suggest that targeting the body’s defense pathways might help treat a subset of people with the psychiatric disorder. But many open questions remain.

Animals with human cells could provide donor organs or help us understand neuropsychiatric disorders.

Adapted from image by I.I. Gottesman ©2001  GENES AND MORE: The risks of developing schizophrenia over a lifetime to the relatives of schizophrenia sufferers accord with a largely genetic explanation. Yet with 48% concordance for identical twins, environmental factors may play a role. It's a scary thought that one could develop a debilitating mental illness such as schizophrenia as easily as catching a cold. Well, it's more complicated than that, say advocates of the so-called infec

The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.

The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.

Glial cells were once considered neurons’ supporting actors, but new methods and model organisms are revealing their true importance in brain function.

Neuroscientists are automating neural imaging and recording, allowing them to monitor increasingly large swaths of the brain in living, behaving animals.
 

From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.

Biology happens on many levels, from ecosystems to electron transport chains. These tools may help spur discoveries at all of life's scales.

The scientific community said goodbye to a number of leading researchers this year.